Sanofi Upgrades 2024 Business EPS Guidance, Now Expects It To Be Stable At CER From A Prior Forecast Of A Slight Decrease, With A Currency Impact Of -5.5% To -6.5%
Portfolio Pulse from Benzinga Newsdesk
Sanofi has upgraded its 2024 business EPS guidance, now expecting it to be stable at constant exchange rates (CER) instead of a slight decrease. However, the currency impact is projected to be between -5.5% to -6.5%.
July 25, 2024 | 5:43 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sanofi has upgraded its 2024 business EPS guidance to stable at CER, an improvement from the previous forecast of a slight decrease. However, the company expects a negative currency impact of -5.5% to -6.5%.
The upgrade in EPS guidance is a positive development, indicating better-than-expected performance driven by Sanofi's pipeline transformation. However, the negative currency impact tempers the overall positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100